Non‐steroidal anti‐inflammatory drugs as disease‐modifying agents for Parkinson's disease: evidence from observational studies

K Rees, R Stowe, S Patel, N Ives… - Cochrane Database …, 2011 - cochranelibrary.com
K Rees, R Stowe, S Patel, N Ives, K Breen, CE Clarke, Y Ben‐Shlomo
Cochrane Database of Systematic Reviews, 2011•cochranelibrary.com
Non‐steroidal anti‐inflammatory drugs as disease‐modifying agents for Parkinson's disease:
evidence from observational studies - Rees, K - 2011 | Cochrane Library Skip to Content
Cookies Our site uses cookies to improve your experience. You can find out more about our
use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to
do so. By continuing to browse this site you agree to us using cookies as described in About
Cookies. I accept The Cochrane Library Cochrane Library logo Trusted evidence. Informed …
Background
Neuroinflammation may play a key role in the neurodegeneration associated with Parkinson's disease (PD). Non‐steroidal anti‐inflammatory drugs (NSAIDs) may be beneficial in the primary and secondary prevention of PD.
Objectives
cochranelibrary.com
Show moreShow less
Save Cite Cited by 201 Related articles All 8 versions